Comment. We were able to calculate the frequency of inadvertent vein or peripheral nerve biopsy from 1 other report. 2 In that study, 4 of 250 consecutive biopsies (1.6%) were of either a nerve or vein rather than an artery, a result that fell within our 95% confidence interval. These estimates provide physicians with some guidelines on how to inform patients of the risk of repeat biopsy. Given the inconvenience, potential morbidity, cost of repeat temporal artery biopsy, and delay in obtaining a final diagnosis, efforts should be made to reduce the frequency of inadvertent biopsy as much as possible. The principle reason for inadvertent biopsy is unclear but may include lack of surgical experience or inadequate visualization of the tissue at the time of removal. Reducing inadvertent biopsies can be achieved first by raising awareness of the phenomenon and then by including a standardized procedure to confirm the correct tissue at the time of harvest. One method could use a magnifying lens (Ն5ϫ) to inspect the cut ends of the putative artery immediately after excision. These inexpensive lenses, which can be sterilized and packaged for use during surgery, have magnification sufficient to aid in the distinction of an artery of this caliber from a vein or nerve. undus albipunctatus was originally thought to be a stationary disease. Lauber 1 first described fundus albipunctatus and differentiated it from retinitis punctata albescens (a progressive tapetoretinal degeneration). Several investigators, however, recently suggested that cone dystrophy gradually develops in some patients. [2] [3] [4] It was reported that mutations of the 11-cis-retinol dehydrogenase (RDH5) gene, which is expressed predominantly in the retinal pigment epithelium (RPE), cause fundus albipunctatus. 5 
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In this article, we show by high-definition optical coherence tomography (OCT) in vivo the disruption of the photoreceptor (PR) layer and hyperreflective lesions located in the inner part of the RPE in a patient with fundus albipunctatus associated with cone dystrophy.
Report of a Case.
A 47-year-old woman was referred to our department for gradual progression of visual impairment, including constriction of the visual field, night blindness, and photophobia. The patient, who had initially noticed poor night vision during childhood, was clinically diagnosed with fundus albipunctatus a few years earlier by a local ophthalmologist; this diagnosis was then confirmed by direct genomic sequencing, showing a homozygous Gly35Ser mutation of the RDH5 gene. The patient signed a comprehensive consent form according to good clinical practice guidelines before proceeding with any examinations. Best-corrected visual acuity was 20/80 OU. Fundus examination revealed numerous yellow-white flecks throughout the midperipheral to far-peripheral retina, and the maculae each showed a bull's-eye lesion (Figure 1) . Fundus autofluorescence showed an abnormal circular hypoautofluorescence within the macular area surrounded by a hyperautofluorescent halo in both eyes (Figure 1 ). The standard flash electroretinogram disclosed severely decreased a-and b-waves in both eyes after 30 minutes of dark adaptation. After 2 hours of dark adaptation, standard flash electroretinogram a-and b-waves showed recovery, (Figure 2) . Moreover, in correspondence with retinal flecks, we observed hyperreflective lesions seen as dome-shaped deposits located in the inner part of the RPE layer and at the level of the outer segment of the PR continuous with the RPE layer (Figure 2) .
Comment.
High-definition OCT is a high-speed OCT system using spectral-or Fourier-domain detection with an axial image resolution of 5 µm. Hence, in vivo visualization of intraretinal structures and especially the RPE as well as the inner segment and outer segment of the PR layer is possible. In our patient, high-definition OCT allowed not only visualization of transverse PR loss in the foveal region but also, in correspondence with retinal flecks, hyperreflective lesions located in the inner part of the RPE, similar to type 1 lesions reported for Stargardt disease. 6 Moreover, these high-definition OCT hyperreflective lesions due to a deficiency of 11-cis-retinol dehydrogenase look similar to the retinal deposits reported by Berson 7 in squirrels that are deprived of vitamin A by dietary restriction.
To our knowledge, there is no histopathologic study of eyes with fundus albipunctatus and no previous description of the layer within the retina in which the flecks in this disease occur. In conclusion, we show in vivo the disruption of the PR layer in fundus albipunctatus (a disease caused by a gene [RDH5] expressed in the RPE) associated with cone dystrophy as well as hyperreflective lesions similar to those reported for Stargardt disease (a disease caused by a gene [ABCA4] expressed in the PR). This may be the first solid evidence indicating the location of the flecks in fundus albipunctatus.
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COMMENTS AND OPINIONS

Methodologic Aspects of Glaucoma Phamacogenomic Studies
M cCarty et al 1 studied the association between intraocular pressure (IOP) response to topical ␤-blockers and genotype. Several factors are associated with IOP response such as concurrent use of IOP-lowering medication, 1 baseline IOP, 2-4 and cup-disc ratio. 4 Patients' races were not provided. Whether treatment was monocular might matter because of association with glaucoma type (eg, angle recession) and because binocular treatment provides 2 opportunities for a specified pressure drop. The criteria of McCarty et al might have included patients with ocular hypertension, primary open-angle glaucoma, or glaucoma due to chronic angle closure, pseudoexfoliation, angle recession, pigmentary change, steroid response, uveitis, neovascularization, or other causes. Genotyping will be most helpful when it provides information not already known. Race, concurrent IOPlowering medication regimen, baseline IOP, type of glaucoma, number of eyes treated, and cup-disc ratio should be controlled for in the multivariable prediction of IOP response ( 
